Skip to content
Sign in
Business opportunities for Wink Biotherapeutics

Compatibility /100

63/100

High potential

Why talk

  1. Wink Biotherapeutics likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
  2. Yo-Kai Express Inc. has strong traction in a related sector (Agri & FoodTech): More than 250 ramen vending machines deployed (SFO, Tesla factories, Ueno station), according to Taiwan News 2025 — a proven go-to-market and customer relationships Wink Biotherapeutics can learn from or tap.
  3. Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers19.3Market bridge8.8Customer potential12.8Sector synergy12.8Stage complementarity9.0

Dimension by dimension

Needs ↔ offers

19.3 / 35 pts

Yo-Kai Express Inc. can help Wink Biotherapeutics.

  • Wink Biotherapeutics likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
  • Wink Biotherapeutics likely needs first paying customers — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer access to its customer base (inferred from public profile).

Market bridge

8.8 / 25 pts

Distant markets.

  • Both are based in United States: shared local customers, investors and ecosystem.

Customer potential

12.8 / 15 pts

Strong customer or channel potential.

  • Yo-Kai Express Inc. has strong traction in a related sector (Agri & FoodTech): More than 250 ramen vending machines deployed (SFO, Tesla factories, Ueno station), according to Taiwan News 2025 — a proven go-to-market and customer relationships Wink Biotherapeutics can learn from or tap.

Sector synergy

12.8 / 15 pts

Complementary sectors.

  • Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.

Stage complementarity

9.0 / 10 pts

Strong mentoring / investor-intro potential.

  • Yo-Kai Express Inc. has raised about $19M — investor introductions are realistic.
  • Yo-Kai Express Inc. (Series A) is well ahead of Wink Biotherapeutics (Pre-seed): mentoring and investor intros.

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “All goals”: Needs ↔ offers 35, Market bridge 25, Customer potential 15, Sector synergy 15, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 58/100 — high from 50, medium from 36.